Skip to main content
Log in

Polymorphism 192Q/R of the paraoxonase 1 gene in elderly men and long-lived people of the Tatar ethnic group

  • Genomics. Transcriptomics. Proteomics
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

To study the molecular genetic basis of human aging and longevity, the allele and genotype frequencies of the 192Q/R polymorphism of PON1 were compared for ethnic Tatars of the younger (1–20 years), middle (21–55 years), elderly (56–74 years), senile (75–89 years), and long-lived (90–109 years) age groups (in total, 1116 people). The PON1 alleles were identified using PCR and restriction enzyme analysis. In the total samples, the frequencies of genotypes Q/Q, Q/R, and R/R were 46.15, 44.35, and 9.5%, respectively, and the frequencies of alleles Q and R were 68.32 and 31.68%, respectively. Some age groups significantly differed from each other in allele and genotype frequencies. The frequency of allele R in the senile group (28.46%) was significantly lower than in the younger group (37.42%, P = 0.009). However, the long-lived displayed significantly higher frequencies of allele R (P = 0.005) and genotype R/R (P = 0.01) as compared with the senile group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Christensen K., Johnson T., Vaupel J. 2006. The quest for genetic determinants of human longevity: Challenges and insights. Nat. Rev. Genet. 7, 436–448.

    Article  PubMed  CAS  Google Scholar 

  2. Butler R., Sprott R., Austad S., et al. 2003. Longevety genes: From primitive organisms to humans. An Interdisciplinary Workshop of the International Longevity Center-USA. www.ilcusa.org.

  3. Orr W., Sohal R. 1994. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263, 1128–1130.

    CAS  Google Scholar 

  4. Moskovitz J., Bar-Noy S., Williams W. et al. 2001. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA. 98, 12,920–12,925.

    Article  CAS  Google Scholar 

  5. Ruan H., Tang X.D., Chen M.-L. et al. 2002. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA. 99, 2748–2753.

    Article  PubMed  CAS  Google Scholar 

  6. Mackness M., Mackness B., Durrington P. et al. 1996. Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol. 7, 69–76.

    Article  PubMed  CAS  Google Scholar 

  7. Seres I., Paragh G., Deschene E., et al. 2004. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol. 39, 59–66.

    Article  PubMed  CAS  Google Scholar 

  8. La Du B., Aviram M., Billecke S., et al. 1999. On the physiological role(s) of the paraoxonases. Chem.-Biol. Interact. 119, 379–388.

    Article  PubMed  Google Scholar 

  9. Deakin S., James R. 2004. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci. 107, 435–447.

    Article  PubMed  CAS  Google Scholar 

  10. Leviev I., Franco N., James R. 1997. Two alleles of the human paraoxonase gene produce different amounts of mRNA: An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler. Thromb. Vasc. Biol. 17, 2935–2939.

    PubMed  CAS  Google Scholar 

  11. Mackness B., Mackness M., Arrol S., et al. 1998. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 423, 57–60.

    Article  PubMed  CAS  Google Scholar 

  12. Davies H., Richter R., Keifer M., et al. 1996. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14, 334–336.

    Article  PubMed  CAS  Google Scholar 

  13. Deakin S., Leviev I., Brulhart-Meynet M., James R. 2003. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position-107, implicating the Sp1 transcription factor. Biochem. J. 372, 643–649.

    Article  PubMed  CAS  Google Scholar 

  14. Scacchi R. 2003. New data on the world distribution of paraoxonase (PON1 Gln192-Arg) gene frequencies. Human Biol. 75, 365–373.

    Article  PubMed  CAS  Google Scholar 

  15. Campoa S., Sardoa M., Trimarchib G., et al. 2004. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and levels in healthy Sicilian octogenarians. Exp. Gerontol. 39, 1089–1094.

    Article  CAS  Google Scholar 

  16. Rea I., McKeown P., McMaster D., et al. 2004. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp. Gerontol. 39, 629–635.

    Article  PubMed  CAS  Google Scholar 

  17. Bonafe M., Marchegiani F., Cardelli M., et al. 2002. Genetic analysis of paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur. J. Hum. Genet. 10, 292–296.

    Article  PubMed  CAS  Google Scholar 

  18. Khrisanfova E.N. 1999. Osnovy gerontologii (Fundamentals of Gerontology). Moscow: VLADOS.

    Google Scholar 

  19. Sambrook J., Fritsch E., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Habor Lab. Press.

    Google Scholar 

  20. Aynaciogly A., Kepekci Y. 2000. The human paraoxonase Gln-Arg 192 (Q/R) polymorphism in Turkish patients with coronary artery disease. Int. J. Cardiol. 74, 33–37.

    Article  Google Scholar 

  21. Roff P., Bentzen P. 1989. The statistical analysis of DNA polymorphism gC2 and problem of small samples. Mol. Biol. Evol. 6, 539–545.

    PubMed  CAS  Google Scholar 

  22. Gardemann A., Philipp M., Hess K., et al. 2000. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis. 152, 421–431.

    Article  PubMed  CAS  Google Scholar 

  23. Pati N., Pati U. 1998. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects. Inter. J. Cardiol. 66, 165–168.

    Article  CAS  Google Scholar 

  24. Pfohl M., Koch M., Enderle M. et. al. 1999. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes. 48, 623–627.

    Article  PubMed  CAS  Google Scholar 

  25. Sanghera D., Saha N., Aston C., et al. 1997. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 17, 1067–1073.

    PubMed  CAS  Google Scholar 

  26. Sen-Banerjee S., Siles S., Campos H. 2000. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 20, 2120–2126.

    PubMed  CAS  Google Scholar 

  27. Ruiz J., Blanche H., James R. et al. 1995. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 345, 869–872.

    Article  Google Scholar 

  28. Odawara M., Tachi Y., Yamashita K. 1997. Paraoxonase polymorphism (Gln192Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 2257–2260.

    Article  PubMed  CAS  Google Scholar 

  29. Imai Y., Morita H., Kurihara H., et al. 2000. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis. 149, 435–442.

    Article  PubMed  CAS  Google Scholar 

  30. Ito T., Yasue H., Yoshimira S., et al. 2002. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum. Genet. 110, 89–94.

    Article  PubMed  CAS  Google Scholar 

  31. Mustafina O.E., Nasibuillin T.R., Tuktarova I.A., et al. 2004. Molecular-genetic analysis of essential hypertension and ischemic heart disease: Analysis of associations with polymorphic markers of candidate genes. Mol. Genet. 6, 269–274.

    Google Scholar 

  32. Durrington P., Mackness B., Mackness M. 2001. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 473–480.

    PubMed  CAS  Google Scholar 

  33. Mackness B., Durrington P., McElduff P., et al. 2003. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation. 107, 2775–2779.

    Article  PubMed  CAS  Google Scholar 

  34. Van der Gaag M., Van Tol A., Scheek L., et al. 1999. Daily moderate alcohol consumption increases serum paraoxonase activity: A diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis. 147, 405–410.

    Article  PubMed  Google Scholar 

  35. Heinecke J., Lusis A. 1998. Paraoxonase-gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis? Am. J. Hum. Genet. 62, 20–24.

    Article  PubMed  CAS  Google Scholar 

  36. Heijmans B., Westendorp R., Lagaay A., et al. 2000. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis. 149, 91–97.

    Article  PubMed  CAS  Google Scholar 

  37. Christiansen L., Bathum L., Frederiksen H., Christensen K. 2004. Paraoxonase 1 polymorphisms and survival. Eur. J. Hum. Genet. 12, 843–847.

    Article  PubMed  CAS  Google Scholar 

  38. Zintzaraz E., Hadjigeorgiou G. 2004. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson’s disease: A meta-analysis. J. Hum. Genet. 49, 474–481.

    Google Scholar 

  39. Shi J., Zhang S., Ma C., et al. 2004. Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer’s disease in Chinese. Di Yi Jun Yi Da Xue Xue Bao. 24, 371–374.

    PubMed  CAS  Google Scholar 

  40. Polaa R., Gaetania E., Flexa A., et al. 2003. Lack of association between Alzheimer’s disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in Italian population. Dementia Geriatric Disorders. 15, 88–91.

    Article  Google Scholar 

  41. Erlich P., Lunetta K., Cupples L., et al. 2006. Polymorphisms in the PON gene cluster are associated with Alzheimer’s disease. Hum. Molec. Genet. 15, 77–85.

    Article  PubMed  CAS  Google Scholar 

  42. Furlong C., Cole T., Jarvik G., et al. 2005. Role of paraoxonase (PON1) status in pesticide sensitivity: Genetic and temporal determinants. Neurotoxicology. 26, 651–659.

    Article  PubMed  CAS  Google Scholar 

  43. Schächter1 F., Faure-Delanef1 L., Guénot1 F., et al. 1994. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6, 29–32.

    Article  Google Scholar 

  44. Seripa D., Franceschi M., Matera M., et al. 2006. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: A population-based study from Southern Italy. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 61, 918–923.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. V. Pauk.

Additional information

Original Russian Text © V.V. Pauk, I.A. Tuktarova, T.R. Nasibullin, L.P. Zueva, A.Kh. Adelguzhina, E.K. Khusnutdinova, O.E. Mustafina, 2007, published in Molekulyarnaya Biologiya, 2007, Vol. 41, No. 4, pp. 601–607.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pauk, V.V., Tuktarova, I.A., Nasibullin, T.R. et al. Polymorphism 192Q/R of the paraoxonase 1 gene in elderly men and long-lived people of the Tatar ethnic group. Mol Biol 41, 539–545 (2007). https://doi.org/10.1134/S0026893307040036

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893307040036

Key words

Navigation